Is Camp4 Therapeutics Corp (CAMP) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 4.0% / 30% | 29.4% / 30% | 0.0% / 30% | 203.99% / 5% | ✗ NOT HALAL |
| DJIM | 4.0% / 33% | 29.4% / 33% | 0.0% / 33% | 203.99% / 5% | ✗ NOT HALAL |
| MSCI | 11.0% / 33% | 81.8% / 33% | 0.1% / 33% | 203.99% / 5% | ✗ NOT HALAL |
| S&P | 4.0% / 33% | 29.4% / 33% | 0.0% / 33% | 203.99% / 5% | ✗ NOT HALAL |
| FTSE | 11.0% / 33% | 81.8% / 33% | 0.1% / 50% | 203.99% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | -3671.3% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -145.1% | |
| Return on Assets (ROA) | -33.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$46M |
| Free Cash Flow | -$46M |
| Total Debt | $9M |
| Debt-to-Equity | 4.2 |
| Current Ratio | 7.4 |
| Total Assets | $78M |
Price & Trading
| Last Close | $4.56 |
| 50-Day MA | $4.54 |
| 200-Day MA | $3.46 |
| Avg Volume | 202K |
|
52-Week Range
$1.30
| |
About Camp4 Therapeutics Corp (CAMP)
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Camp4 Therapeutics Corp (CAMP) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Camp4 Therapeutics Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Camp4 Therapeutics Corp's debt ratio?
Camp4 Therapeutics Corp's debt ratio is 4.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 11.0%.
What are Camp4 Therapeutics Corp's key financial metrics?
Camp4 Therapeutics Corp has a market capitalization of $224M, and revenue of $652,000. Return on equity stands at -145.1%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.